GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anixa Biosciences ANIX · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.16

-0.63%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Anixa Biosciences

From its filings with the US Securities and Exchange Commission

SEC filings

Anixa Biosciences is based in San Jose, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ANIX. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 October 2024, it reported revenue of $210,000.

In its own words

Biosciences, Inc. is a biotechnology company developing therapies and vaccines that are focused on critical unmet needs in oncology.

(Keytruda®). In June 2025, we completed enrollment in the Phase 1 trial and in October 2025, we completed all patient clinical visits.

Islander women, and ranges from 92% to 31% based on whether it is first diagnosed at a local stage or a distant stage, respectively.

Expressway, San Jose, California 95118, our telephone number is (408) 708-9808 and our Internet website address is www.anixa.com.

Quoted from its 10-K, filed 12 Jan 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
7 Oct 1983
Employees
4
Website
anixa.com ↗
Head office
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Incorporated in
DE
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Dr. Amit KumarChairman of the Board, Chief Executive Officer, since 2012$2.5m
  • Mr. Michael CatelaniPresident, Chief Financial Officer, Chief Operating Officer, Secretary$1.3m
  • Mr. Lewis TittertonLead Independent Director, since 1999$134,625
  • Dr. Arnold BaskiesIndependent Director$134,625
  • Ms. Emily GottschalkIndependent Director$134,625

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.